Researchers in the Ley Laboratory are currently examining how beta-adrenergic receptor inhibition can reduce secondary injuries after traumatic brain injury (TBI). This topic is pursued through an in vivo genetically modified knockout mouse model targeting the β1-adrenergic/β2-adrenergic receptor and a stereotaxic impact device.
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Ley Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
The Trauma Research Program focuses on facilitating clinical research in the Department of Surgery's Division of Trauma and Critical Care at Cedars-Sinai. The Trauma Research Program provides undergraduate students with firsthand exposure to clinical research at one of the top Level I trauma centers in Los Angeles.
Liou DZ, Barmparas G, Harada M, Chung R, Melo N, Ley EJ, Salim A, Bukur M.
J Surg Educ. 2016 Jan-Feb;73(1):173-179.
Murry JS, Hoang DM, Barmparas G, Harada MY, Bukur M, Bloom MB, Inaba K, Margulies DR, Salim A, Ley EJ.
J Surg Res. 2016 Jan;200(1):221-226.
Zaw AA, Stewart D, Murry JS, Hoang DM, Sun B, Ashrafian S, Hotz H, Chung R, Margulies DR, Ley EJ.
Am Surg. 2016 Jan;82(1):41-45.